HomepageMedicineFDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin Posted on April 4, 2024 Fanapt was previously approved by the FDA in 2009 as an antipsychotic treatment for schizophrenia. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostTemu o optužbama njemačkih potrošačkih organizacija: “Naša praksa je poštena” Next PostHow a Violin Maker’s Dreams Came True in Cremona, Italy You Might Also Like Medicine Navigating Success During a Rare Disease Product Launch admin January 19, 2024 Medicine FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema admin February 5, 2025 Medicine Gen-Z Influence on Pharma M&A admin March 14, 2024 Medicine Big Bets, Bold Steps admin August 14, 2024
Medicine FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema admin February 5, 2025